Investing Profile
Helen Kim
Your Intro Paths to Helen Kim
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Helen is a member of
Hotmail Network
5849 CONNECTIONS
Hotmail Network
5849 CONNECTIONS
Hotmail Network
5849 CONNECTIONS
Hotmail Network
5849 CONNECTIONS
MiOrden.com Network
918 CONNECTIONS
Find Helen Kim on
cbCurrent Investing Position
The Column Group Partner
Investment Range
$100K - $10.0M
Sweet Spot
$1M
Investments On Record
8
Current Fund Size
$600M
Helen Kim is on these Sector & Stage Rankings
Helen Kim's Investments On Record (5)
Sign in to see all 5 investments on record.
Sign in with Google →Helen Kim's Experience
Board director MiOrden.comPresent
Board Member MiOrden.comPresent
Board director UT Jackson School of Geosciences, Invertebrate Paleontology LabPresent
Board Member UT Jackson School of Geosciences, Invertebrate Paleontology LabPresent
Vice President, Marketing and Product Development HotmailPresent
Sr. Vice President, Corporate Development Onyx Pharmaceuticals, Inc., an Amgen subsidiaryPresent
Chief Business Officer HotmailPresent
Chief Program Officer Gordon and Betty Moore FoundationPresent
Board member Trinity BiosystemsPresent
Board Director Sunesis Pharmaceuticals, Inc.Present
Strategic Advisor formerly Chief Business Officer NGM BiopharmaceuticalsPresent
Board member ImmunoCellular Therapeutics LtdPresent
Board director HotmailPresent
Board Member HotmailPresent
Board Member ExicurePresent
Executive Vice President Kite PharmaPresent
Member Board Of Directors Assembly Biosciences, Inc.Present
Board Member Applied Molecular TransportPresent
Board Member A2 Biotherapeutics, Inc.Present
Senior Managing Director Vida Ventures, LLCPresent
Senior Managing Director Vida Ventures, LLC Full-timePresent
Member Board of Directors ReCode TherapeuticsPresent
Member Board of Directors IconOVir BioPresent
Member Board of Directors Aktis OncologyPresent
Member Board of Directors Protego BioPresent
Member Board of Directors InduProPresent
Member Board of Directors Prothena CorporationPresent
President and CEO Kosan BiosciencesPresent
Partner The Column GroupPresent
Helen Kim's Education
Northwestern University BS Chemical Engineering
Investors who invest with Helen Kim
Sign in with Google →Scouts & Angels Affiliated With Helen Kim
Sign in with Google →